Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer

• Conditions: Gastric Cancer

• Registration Number: NCT01848015
• Lead Sponsor: Peking University

Brief Summary

To assess the predictive value of circulating tumor cells (CTCs) for recurrence of advanced gastric cancer after radical resection.

To identify the relationship between the detection of circulation tumor cells and recurrence patterns of gastric cancer after radical resection.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-05-03
• Study First Submitted QC: 2013-05-06
• Study First Posted: 2013-05-07
• Study Start: 2013-06
• Status Verified: 2015-05
• Last Update Submitted: 2015-05-17
• Last Update Posted: 2015-05-19
• Primary Completion: 2016-06
• Study Completion: 2016-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Having signed informed consent
• Age≥ 18 years old
• Histologically confirmed gastric adenocarcinoma
• Preoperative clinical examination and imaging indicating operable disease
• complete resection (R0 resection)
• D2 or D2+ resection

Exclusion Criteria

• Other tumor type than adenocarcinoma
• Patients who have been given preoperative chemotherapy/chemoradiation.
• Staging investigations or intraoperative exploration indicating inoperable disease
• R1 or R2 resection
• D0 or D1 resection
• Patients unreliable for follow up
• Past history of malignancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CTCs	2 months

Secondary Outcome Measures

Name	Time	Method
Recurrence of gastric cancer after radical resection	2 years

Trial Locations

Locations (1)

Peking cancer hospital; 🇨🇳 Beijing, Beijing, China